然而，令人失望的是，仅有20-42%的这些新获批抗肿瘤药物，能够达到由ASCO和ESMO设定的临床获益标准，即延长总生存期超过2.5个月。另外40%新批的抗肿瘤药物延长生存期2周至2.5个月，有30%新批的抗肿瘤药物未能改善总生存期。

indicating drug abuse is considered a detestable crime and is socially rejected. The department enumerated seven methods to identify a drug addict at home as follows: Persistence to do anything to ...

Each year, the National Drug and Alcohol Research Center at UNSW Sydney surveys hundreds of people who regularly use drugs in ...

Advancements in technology have revolutionized drug delivery training. Simulation training offers a realistic and interactive ...

Research in cell cultures and mice demonstrates an antidepressant called vortioxetine may be effective in combating glioblastomas.

THIRUVANANTHAPURAM: Local pharmacists in Kerala are set to play a crucial role in detecting outbreaks of infectious diseases ...

Rideshare drivers have been asking for better safety features to better protect them against carjackings and assaults.

Researchers discovered previously unrecognized oscillatory trends in COVID-19 cases across the U.S., particularly a ...

District Judge Kevin Mullins, 54, was pronounced dead at the scene. Letcher County Sheriff Shawn M. Stines, 43, was arrested ...

Scientists found drugs which target the specific receptors necessary to activate vitamin A may be therapeutic for diseases ...

硫嘌呤类药物广泛用于治疗白血病、风湿性疾病、皮肤病、炎症性肠病以及实体器官移植排斥反应。经典认为该类药物主要通过抑制嘌呤核苷酸、DNA及RNA的合成发挥抗增殖作用。然而该经典药理学机制并不能完全解释其体内活性。

研究成果以“通过综合临床与临床前研究鉴定FerroTerminator1分子为治疗代谢功能障碍相关脂肪性肝炎的潜在药物（Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH）”为题，2024年8月13日在线发表于《细胞代谢》（Cell ...